Andre Watson Shares What's Missing from the Gene...
Feb. 22, 2021
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Ligandal
Main focus: Novel delivery technologies
Company stage: Pre-clinical
Diseases: Undisclosed
Genome editing tool: CRISPR-Cas9
Funding stage: Private
Location: San Francisco, CA, US
Website: https://www.ligandal.com/
Ligandal is a US-based, privately held biotech company focused on improving delivery systems for gene therapies. Ligandal creates bioinspired nanomaterials that more effectively deliver CRISPR reagents into the nucleus of T cells, which is the company's main target cell. The nanomaterials are developed from ligand-binding motifs derived from natural proteins interacting with the protein of interest.
